Current therapies and new developments in NASH.

Dufour, Jean-François; Anstee, Quentin M; Bugianesi, Elisabetta; Harrison, Stephen; Loomba, Rohit; Paradis, Valerie; Tilg, Herbert; Wong, Vincent Wai-Sun; Zelber-Sagi, Shira

Dufour, Jean-François; Anstee, Quentin M; Bugianesi, Elisabetta; Harrison, Stephen; Loomba, Rohit; Paradis, Valerie; Tilg, Herbert; Wong, Vincent Wai-Sun; Zelber-Sagi, Shira.

Afiliação

Dufour JF; Centre des Maladies Digestives, Lausanne, Switzerland jf.dufour@svmed.ch.
Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Bugianesi E; Medical Sciences, University of Turin, Torino, Italy.
Harrison S; Pinnacle clinical research, San Antonio, Texas, USA.
Loomba R; Visiting Professor of Hepatology, University of Oxford, Oxford, UK.
Paradis V; Division of Gastroenterology and Epidemiology, University of California at San Diego, La Jolla, California, USA.
Tilg H; Pathology Department, Hopital Beaujon, Clichy, France.
Wong VW; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria.
Zelber-Sagi S; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, Hong Kong.

Gut ; 2022 Jun 16.

Article em En | MEDLINE | ID: mdl-35710299

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google